Literature DB >> 27251377

The role of IL-37 in cancer.

Vivi A Ding1, Ziwen Zhu2, Huaping Xiao3, Mark R Wakefield2, Qian Bai2, Yujiang Fang4,5.   

Abstract

Interleukin 37 (IL-37) is a new member of the IL-1 family which all have a similar β-barrel structure. Since its discovery, IL-37 has been studied extensively in immunological field. It has been established that IL-37 possesses anti-inflammatory characteristics both in innate immune response as well as in acquired immune responses by downregulating pro-inflammatory molecules. This review will discuss the role of IL-37 in immunological processes and neoplastic pathogenesis.

Entities:  

Keywords:  Cancer; IL-37; Immunity

Mesh:

Substances:

Year:  2016        PMID: 27251377     DOI: 10.1007/s12032-016-0782-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  35 in total

1.  Transfer of the IL-37b gene elicits anti-tumor responses in mice bearing 4T1 breast cancer.

Authors:  Wei-qiang Wang; Dan Zhao; Yu-shan Zhou; Xiao-yu Hu; Zhi-na Sun; Gang Yu; Wan-tong Wu; Song Chen; Jiu-long Kuang; Guo-gang Xu; Zhong-chao Han; Bang-mao Wang; Jing-xian Yang; Xiao-ming Feng
Journal:  Acta Pharmacol Sin       Date:  2015-04       Impact factor: 6.150

2.  Four new members expand the interleukin-1 superfamily.

Authors:  D E Smith; B R Renshaw; R R Ketchem; M Kubin; K E Garka; J E Sims
Journal:  J Biol Chem       Date:  2000-01-14       Impact factor: 5.157

3.  IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp.

Authors:  G Pan; P Risser; W Mao; D T Baldwin; A W Zhong; E Filvaroff; D Yansura; L Lewis; C Eigenbrot; W J Henzel; R Vandlen
Journal:  Cytokine       Date:  2001-01-07       Impact factor: 3.861

4.  IL-1 family nomenclature.

Authors:  Charles Dinarello; William Arend; John Sims; Dirk Smith; Hal Blumberg; Luke O'Neill; Raphaela Goldbach-Mansky; Theresa Pizarro; H Hoffman; Philip Bufler; Marcel Nold; Pietro Ghezzi; Alberto Mantovani; Cecilia Garlanda; Diana Boraschi; Anna Rubartelli; Mihai Netea; Jos van der Meer; Leo Joosten; Tom Mandrup-Poulsen; Marc Donath; Eli Lewis; Josef Pfeilschifter; Michael Martin; Michael Kracht; H Muehl; Daniela Novick; Miodrag Lukic; Bruno Conti; Alan Solinger; Peyman Kelk; Kelk Peyman; Frank van de Veerdonk; Chiristopher Gabel
Journal:  Nat Immunol       Date:  2010-11       Impact factor: 25.606

5.  Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.

Authors:  Suzhao Li; C Preston Neff; Kristina Barber; Jaewoo Hong; Yuchun Luo; Tania Azam; Brent E Palmer; Mayumi Fujita; Cecilia Garlanda; Alberto Mantovani; Soohyun Kim; Charles Anthony Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-05       Impact factor: 11.205

Review 6.  Immunobiology of IL-37: mechanism of action and clinical perspectives.

Authors:  Shannon Quirk; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2014-10-18       Impact factor: 4.473

7.  Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity.

Authors:  Wentao Gao; Sanjay Kumar; Michael T Lotze; Charles Hanning; Paul D Robbins; Andrea Gambotto
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

8.  Interleukin 37 Expression Inhibits STAT3 to Suppress the Proliferation and Invasion of Human Cervical Cancer Cells.

Authors:  Sen Wang; Weifang An; Yunhong Yao; Renhuai Chen; Xiaoxuan Zheng; Wanyong Yang; Yi Zhao; Xinrong Hu; Enping Jiang; Yanhong Bie; Zhangquan Chen; Ping Ouyang; He Zhang; Hui Xiong
Journal:  J Cancer       Date:  2015-08-08       Impact factor: 4.207

Review 9.  How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

Authors:  Ole Audun Werner Haabeth; Anders Aune Tveita; Marte Fauskanger; Fredrik Schjesvold; Kristina Berg Lorvik; Peter O Hofgaard; Hilde Omholt; Ludvig A Munthe; Zlatko Dembic; Alexandre Corthay; Bjarne Bogen
Journal:  Front Immunol       Date:  2014-04-15       Impact factor: 7.561

10.  Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma: role for CD57+ NK cells.

Authors:  Jing-Jing Zhao; Qiu-Zhong Pan; Ke Pan; De-Sheng Weng; Qi-Jing Wang; Jian-Jun Li; Lin Lv; Dan-Dan Wang; Hai-Xia Zheng; Shan-Shan Jiang; Xiao-Fei Zhang; Jian-Chuan Xia
Journal:  Sci Rep       Date:  2014-06-05       Impact factor: 4.379

View more
  14 in total

1.  Development and characterization of monoclonal antibody against human IL-37b.

Authors:  Yu-Chi Gao; Yan Jia; De-Qian Xiao; Xin Wang; You-Chao Dai; Shi-Yan Yu; Chen Chen; Ze-Gang Zhuang; Xiao-Xia Fu; Jun-Ai Zhang; Bi-Ying Zheng; Zhi-Hong Chen; Ji-Xin Zhong; Zhang-Quan Chen; Jun-Fa Xu
Journal:  Cytotechnology       Date:  2017-02-18       Impact factor: 2.058

2.  Influenza A virus inhibits influenza virus replication by inducing IL-37.

Authors:  Feng Zhou; Cheng-Liang Zhu; Zhi-Li Niu; Feng-Xia Xu; Hui Song; Xing-Hui Liu
Journal:  J Clin Lab Anal       Date:  2018-08-11       Impact factor: 2.352

3.  IL-10 and its related superfamily members IL-19 and IL-24 provide parallel/redundant immune-modulation in Loa loa infection.

Authors:  Alessandra Ricciardi; Thomas B Nutman
Journal:  J Infect Dis       Date:  2020-06-19       Impact factor: 5.226

4.  Interleukin-37 monomer is the active form for reducing innate immunity.

Authors:  Elan Z Eisenmesser; Adrian Gottschlich; Jasmina S Redzic; Natasia Paukovich; Jay C Nix; Tania Azam; Lingdi Zhang; Rui Zhao; Jeffrey S Kieft; Erlinda The; Xianzhong Meng; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-28       Impact factor: 11.205

Review 5.  The role of interleukins and the widely studied TNF-α in non-Hodgkin's lymphoma.

Authors:  Kyle P D'mello; Lei Zhao; Erin C Kaser; Ziwen Zhu; Huaping Xiao; Mark R Wakefield; Qian Bai; Yujiang Fang
Journal:  Med Oncol       Date:  2021-04-09       Impact factor: 3.064

Review 6.  The Role of IL-37 in Non-Cancerous Diseases.

Authors:  Vivi A Ding; Ziwen Zhu; Alyse A Mantz; Huaping Xiao; Mark R Wakefield; Qian Bai; Yujiang Fang
Journal:  Pathol Oncol Res       Date:  2016-10-27       Impact factor: 3.201

7.  IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1/NF-κB/MMP2 signal pathway.

Authors:  Xishuang Wang; Zengtao Wei; Zhongyun Tang; Chenyue Xue; Huayun Yu; Derui Zhang; Yulan Li; Xihong Liu; Yongyu Shi; Lining Zhang; Guoling Chen; Huaiyu Zhou; Jianing Wang; Xiaoyan Wang
Journal:  Lab Invest       Date:  2021-03-22       Impact factor: 5.662

8.  The novel role of IL-37 in prostate cancer: evidence as a promising radiosensitizer.

Authors:  Vivi A Ding; Ziwen Zhu; Timothy A Steele; Mark R Wakefield; Huaping Xiao; Dean Balabanov; Yujiang Fang
Journal:  Med Oncol       Date:  2017-12-05       Impact factor: 3.064

9.  Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy.

Authors:  Lijuan Wang; Yanchun Quan; Yongfang Yue; Xueyuan Heng; Fengyuan Che
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

Review 10.  IL-37: An anti-inflammatory cytokine with antitumor functions.

Authors:  Yu Mei; Haiyan Liu
Journal:  Cancer Rep (Hoboken)       Date:  2018-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.